Iceland

Iceland

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.65 (0.53 - 0.77) 2019 Modelled IHME
0.65 (0.53 - 0.76) 2018 Modelled IHME
0.65 (0.53 - 0.78) 2017 Modelled IHME
0.66 (0.54 - 0.79) 2016 Modelled IHME
0.67 (0.54 - 0.80) 2015 Modelled IHME
0.67 (0.54 - 0.80) 2014 Modelled IHME
0.67 (0.54 - 0.79) 2013 Modelled IHME
0.67 (0.54 - 0.80) 2012 Modelled IHME
0.67 (0.54 - 0.80) 2011 Modelled IHME
0.67 (0.54 - 0.80) 2010 Modelled IHME
0.67 (0.54 - 0.80) 2009 Modelled IHME
0.67 (0.55 - 0.79) 2008 Modelled IHME
0.68 (0.55 - 0.79) 2007 Modelled IHME
0.68 (0.56 - 0.80) 2006 Modelled IHME
0.68 (0.56 - 0.81) 2005 Modelled IHME
0.68 (0.57 - 0.81) 2004 Modelled IHME
0.69 (0.57 - 0.81) 2003 Modelled IHME
0.69 (0.58 - 0.82) 2002 Modelled IHME
0.7 (0.58 - 0.83) 2001 Modelled IHME
0.7 (0.57 - 0.84) 2000 Modelled IHME
0.7 (0.58 - 0.83) 1999 Modelled IHME
0.7 (0.58 - 0.84) 1998 Modelled IHME
0.7 (0.57 - 0.83) 1997 Modelled IHME
0.7 (0.57 - 0.83) 1996 Modelled IHME
0.7 (0.57 - 0.84) 1995 Modelled IHME
0.71 (0.57 - 0.85) 1994 Modelled IHME
0.71 (0.57 - 0.85) 1993 Modelled IHME
0.71 (0.57 - 0.86) 1992 Modelled IHME
0.72 (0.57 - 0.87) 1991 Modelled IHME
0.72 (0.56 - 0.89) 1990 Modelled IHME
0.89 (0.06 - 10.33) 2015 Modelled WHO
0.14 (0.04 - 0.56) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.3 (0.20 - 0.41) 2019 Modelled IHME
0.31 (0.20 - 0.43) 2018 Modelled IHME
0.31 (0.20 - 0.44) 2017 Modelled IHME
0.32 (0.20 - 0.44) 2016 Modelled IHME
0.32 (0.20 - 0.45) 2015 Modelled IHME
0.32 (0.21 - 0.45) 2014 Modelled IHME
0.32 (0.21 - 0.45) 2013 Modelled IHME
0.31 (0.21 - 0.44) 2012 Modelled IHME
0.31 (0.21 - 0.44) 2011 Modelled IHME
0.31 (0.21 - 0.44) 2010 Modelled IHME
0.31 (0.21 - 0.44) 2009 Modelled IHME
0.31 (0.21 - 0.43) 2008 Modelled IHME
0.32 (0.22 - 0.43) 2007 Modelled IHME
0.32 (0.22 - 0.43) 2006 Modelled IHME
0.32 (0.22 - 0.43) 2005 Modelled IHME
0.33 (0.22 - 0.43) 2004 Modelled IHME
0.33 (0.22 - 0.44) 2003 Modelled IHME
0.34 (0.23 - 0.45) 2002 Modelled IHME
0.35 (0.23 - 0.46) 2001 Modelled IHME
0.35 (0.23 - 0.47) 2000 Modelled IHME
0.35 (0.24 - 0.46) 1999 Modelled IHME
0.35 (0.24 - 0.46) 1998 Modelled IHME
0.34 (0.24 - 0.46) 1997 Modelled IHME
0.34 (0.24 - 0.46) 1996 Modelled IHME
0.34 (0.23 - 0.46) 1995 Modelled IHME
0.34 (0.23 - 0.46) 1994 Modelled IHME
0.34 (0.23 - 0.46) 1993 Modelled IHME
0.34 (0.24 - 0.47) 1992 Modelled IHME
0.35 (0.24 - 0.49) 1991 Modelled IHME
0.35 (0.24 - 0.51) 1990 Modelled IHME
0.88 (0.06 - 10.46) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
1,827 (1,425 - 2,256) 1990 Modelled IHME
1,836 (1,454 - 2,233) 1991 Modelled IHME
1,846 (1,473 - 2,235) 1992 Modelled IHME
1,857 (1,492 - 2,237) 1993 Modelled IHME
1,866 (1,502 - 2,239) 1994 Modelled IHME
1,876 (1,508 - 2,246) 1995 Modelled IHME
1,886 (1,526 - 2,240) 1996 Modelled IHME
1,900 (1,542 - 2,250) 1997 Modelled IHME
1,917 (1,570 - 2,279) 1998 Modelled IHME
1,938 (1,596 - 2,302) 1999 Modelled IHME
1,959 (1,599 - 2,337) 2000 Modelled IHME
1,976 (1,633 - 2,348) 2001 Modelled IHME
1,984 (1,646 - 2,349) 2002 Modelled IHME
1,988 (1,637 - 2,347) 2003 Modelled IHME
1,994 (1,652 - 2,360) 2004 Modelled IHME
2,012 (1,662 - 2,381) 2005 Modelled IHME
2,042 (1,683 - 2,408) 2006 Modelled IHME
2,077 (1,704 - 2,441) 2007 Modelled IHME
2,109 (1,726 - 2,491) 2008 Modelled IHME
2,128 (1,726 - 2,522) 2009 Modelled IHME
2,134 (1,720 - 2,543) 2010 Modelled IHME
2,137 (1,728 - 2,549) 2011 Modelled IHME
2,144 (1,735 - 2,559) 2012 Modelled IHME
2,156 (1,751 - 2,563) 2013 Modelled IHME
2,174 (1,767 - 2,613) 2014 Modelled IHME
2,195 (1,791 - 2,651) 2015 Modelled IHME
2,206 (1,807 - 2,647) 2016 Modelled IHME
2,213 (1,802 - 2,641) 2017 Modelled IHME
2,224 (1,816 - 2,600) 2018 Modelled IHME
2,233 (1,827 - 2,641) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.32 (1.02 - 1.72) 2019 Modelled IHME
1.31 (1 - 1.70) 2018 Modelled IHME
1.28 (0.99 - 1.66) 2017 Modelled IHME
1.26 (0.96 - 1.61) 2016 Modelled IHME
1.24 (0.95 - 1.59) 2015 Modelled IHME
1.23 (0.94 - 1.57) 2014 Modelled IHME
1.25 (0.96 - 1.61) 2013 Modelled IHME
1.24 (0.95 - 1.58) 2012 Modelled IHME
1.21 (0.93 - 1.53) 2011 Modelled IHME
1.19 (0.91 - 1.50) 2010 Modelled IHME
1.17 (0.90 - 1.48) 2009 Modelled IHME
1.16 (0.89 - 1.47) 2008 Modelled IHME
1.16 (0.90 - 1.48) 2007 Modelled IHME
1.16 (0.89 - 1.47) 2006 Modelled IHME
1.14 (0.88 - 1.44) 2005 Modelled IHME
1.12 (0.86 - 1.41) 2004 Modelled IHME
1.11 (0.86 - 1.40) 2003 Modelled IHME
1.12 (0.86 - 1.41) 2002 Modelled IHME
1.11 (0.86 - 1.41) 2001 Modelled IHME
1.11 (0.86 - 1.40) 2000 Modelled IHME
1.12 (0.87 - 1.43) 1999 Modelled IHME
1.14 (0.88 - 1.45) 1998 Modelled IHME
1.14 (0.88 - 1.44) 1997 Modelled IHME
1.13 (0.88 - 1.45) 1996 Modelled IHME
1.11 (0.87 - 1.42) 1995 Modelled IHME
1.08 (0.84 - 1.38) 1994 Modelled IHME
1.06 (0.82 - 1.34) 1993 Modelled IHME
1.05 (0.81 - 1.34) 1992 Modelled IHME
1.04 (0.80 - 1.32) 1991 Modelled IHME
1.02 (0.78 - 1.31) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
5 (4 - 6) 2019 Modelled IHME
4 (3 - 6) 2018 Modelled IHME
4 (3 - 6) 2017 Modelled IHME
4 (3 - 5) 2016 Modelled IHME
4 (3 - 5) 2015 Modelled IHME
4 (3 - 5) 2014 Modelled IHME
4 (3 - 5) 2013 Modelled IHME
4 (3 - 5) 2012 Modelled IHME
4 (3 - 5) 2011 Modelled IHME
4 (3 - 5) 2010 Modelled IHME
4 (3 - 5) 2009 Modelled IHME
4 (3 - 5) 2008 Modelled IHME
4 (3 - 5) 2007 Modelled IHME
3 (3 - 4) 2006 Modelled IHME
3 (3 - 4) 2005 Modelled IHME
3 (3 - 4) 2004 Modelled IHME
3 (2 - 4) 2003 Modelled IHME
3 (2 - 4) 2002 Modelled IHME
3 (2 - 4) 2001 Modelled IHME
3 (2 - 4) 2000 Modelled IHME
3 (2 - 4) 1999 Modelled IHME
3 (2 - 4) 1998 Modelled IHME
3 (2 - 4) 1997 Modelled IHME
3 (2 - 4) 1996 Modelled IHME
3 (2 - 4) 1995 Modelled IHME
3 (2 - 4) 1994 Modelled IHME
3 (2 - 4) 1993 Modelled IHME
3 (2 - 3) 1992 Modelled IHME
3 (2 - 3) 1991 Modelled IHME
3 (2 - 3) 1990 Modelled IHME
4 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
14 (10 - 20) 2019 Modelled IHME
14 (10 - 20) 2018 Modelled IHME
14 (10 - 20) 2017 Modelled IHME
14 (10 - 20) 2016 Modelled IHME
14 (10 - 20) 2015 Modelled IHME
14 (10 - 20) 2014 Modelled IHME
14 (10 - 20) 2013 Modelled IHME
14 (10 - 20) 2012 Modelled IHME
14 (10 - 20) 2011 Modelled IHME
14 (10 - 20) 2010 Modelled IHME
14 (10 - 20) 2009 Modelled IHME
14 (10 - 20) 2008 Modelled IHME
14 (10 - 20) 2007 Modelled IHME
14 (10 - 20) 2006 Modelled IHME
14 (10 - 20) 2005 Modelled IHME
14 (10 - 20) 2004 Modelled IHME
14 (10 - 20) 2003 Modelled IHME
14 (10 - 21) 2002 Modelled IHME
15 (10 - 21) 2001 Modelled IHME
15 (10 - 21) 2000 Modelled IHME
15 (10 - 21) 1999 Modelled IHME
15 (10 - 21) 1998 Modelled IHME
15 (10 - 21) 1997 Modelled IHME
15 (10 - 21) 1996 Modelled IHME
15 (10 - 21) 1995 Modelled IHME
15 (10 - 22) 1994 Modelled IHME
15 (10 - 22) 1993 Modelled IHME
15 (11 - 22) 1992 Modelled IHME
15 (11 - 22) 1991 Modelled IHME
15 (11 - 22) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2025
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.63 (0.51 - 0.77) 2019 Modelled IHME
0.63 (0.51 - 0.77) 2018 Modelled IHME
0.62 (0.51 - 0.76) 2017 Modelled IHME
0.61 (0.50 - 0.74) 2016 Modelled IHME
0.6 (0.48 - 0.73) 2015 Modelled IHME
0.59 (0.48 - 0.73) 2014 Modelled IHME
0.6 (0.48 - 0.74) 2013 Modelled IHME
0.6 (0.49 - 0.73) 2012 Modelled IHME
0.6 (0.48 - 0.73) 2011 Modelled IHME
0.6 (0.48 - 0.73) 2010 Modelled IHME
0.59 (0.48 - 0.73) 2009 Modelled IHME
0.59 (0.48 - 0.73) 2008 Modelled IHME
0.59 (0.48 - 0.73) 2007 Modelled IHME
0.59 (0.48 - 0.73) 2006 Modelled IHME
0.59 (0.48 - 0.72) 2005 Modelled IHME
0.58 (0.48 - 0.72) 2004 Modelled IHME
0.58 (0.47 - 0.72) 2003 Modelled IHME
0.58 (0.47 - 0.71) 2002 Modelled IHME
0.57 (0.47 - 0.71) 2001 Modelled IHME
0.57 (0.47 - 0.70) 2000 Modelled IHME
0.57 (0.46 - 0.70) 1999 Modelled IHME
0.56 (0.46 - 0.70) 1998 Modelled IHME
0.56 (0.45 - 0.69) 1997 Modelled IHME
0.55 (0.45 - 0.68) 1996 Modelled IHME
0.55 (0.45 - 0.68) 1995 Modelled IHME
0.55 (0.45 - 0.68) 1994 Modelled IHME
0.55 (0.45 - 0.68) 1993 Modelled IHME
0.55 (0.45 - 0.69) 1992 Modelled IHME
0.55 (0.45 - 0.69) 1991 Modelled IHME
0.55 (0.45 - 0.69) 1990 Modelled IHME
0.3 (0.20 - 0.40) 2015 Modelled Blach et al, 2017
0.3 (0.30 - 0.40) 2014 Modelled Olafsson S et al, 2018
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
63 (59.80 - 66.20) 1993 Survey/reported Love A et al, 1994
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
1,404 (1,134 - 1,746) 1990 Modelled IHME
1,416 (1,150 - 1,764) 1991 Modelled IHME
1,429 (1,165 - 1,780) 1992 Modelled IHME
1,443 (1,173 - 1,785) 1993 Modelled IHME
1,455 (1,180 - 1,806) 1994 Modelled IHME
1,466 (1,191 - 1,822) 1995 Modelled IHME
1,480 (1,202 - 1,834) 1996 Modelled IHME
1,502 (1,221 - 1,864) 1997 Modelled IHME
1,531 (1,249 - 1,899) 1998 Modelled IHME
1,563 (1,270 - 1,924) 1999 Modelled IHME
1,595 (1,299 - 1,968) 2000 Modelled IHME
1,624 (1,323 - 2,004) 2001 Modelled IHME
1,651 (1,344 - 2,037) 2002 Modelled IHME
1,676 (1,367 - 2,066) 2003 Modelled IHME
1,703 (1,391 - 2,096) 2004 Modelled IHME
1,734 (1,410 - 2,137) 2005 Modelled IHME
1,773 (1,450 - 2,186) 2006 Modelled IHME
1,817 (1,487 - 2,248) 2007 Modelled IHME
1,858 (1,517 - 2,303) 2008 Modelled IHME
1,884 (1,531 - 2,329) 2009 Modelled IHME
1,896 (1,539 - 2,336) 2010 Modelled IHME
1,902 (1,547 - 2,347) 2011 Modelled IHME
1,910 (1,558 - 2,355) 2012 Modelled IHME
1,922 (1,563 - 2,375) 2013 Modelled IHME
1,941 (1,577 - 2,382) 2014 Modelled IHME
1,964 (1,592 - 2,420) 2015 Modelled IHME
2,027 (1,656 - 2,480) 2016 Modelled IHME
2,101 (1,721 - 2,580) 2017 Modelled IHME
2,140 (1,752 - 2,620) 2018 Modelled IHME
2,168 (1,770 - 2,651) 2019 Modelled IHME
1,000 (1,000 - 1,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.15 (1.66 - 2.70) 2019 Modelled IHME
2.16 (1.67 - 2.71) 2018 Modelled IHME
2.11 (1.63 - 2.64) 2017 Modelled IHME
2.07 (1.60 - 2.58) 2016 Modelled IHME
2.02 (1.55 - 2.54) 2015 Modelled IHME
1.99 (1.54 - 2.48) 2014 Modelled IHME
2.03 (1.58 - 2.52) 2013 Modelled IHME
1.99 (1.54 - 2.46) 2012 Modelled IHME
1.92 (1.50 - 2.36) 2011 Modelled IHME
1.85 (1.45 - 2.27) 2010 Modelled IHME
1.8 (1.41 - 2.21) 2009 Modelled IHME
1.77 (1.38 - 2.17) 2008 Modelled IHME
1.76 (1.38 - 2.16) 2007 Modelled IHME
1.73 (1.35 - 2.12) 2006 Modelled IHME
1.7 (1.34 - 2.08) 2005 Modelled IHME
1.65 (1.32 - 2.02) 2004 Modelled IHME
1.63 (1.30 - 1.99) 2003 Modelled IHME
1.61 (1.29 - 1.96) 2002 Modelled IHME
1.59 (1.28 - 1.93) 2001 Modelled IHME
1.57 (1.26 - 1.90) 2000 Modelled IHME
1.59 (1.27 - 1.92) 1999 Modelled IHME
1.6 (1.28 - 1.94) 1998 Modelled IHME
1.58 (1.27 - 1.92) 1997 Modelled IHME
1.56 (1.25 - 1.89) 1996 Modelled IHME
1.51 (1.21 - 1.82) 1995 Modelled IHME
1.44 (1.15 - 1.73) 1994 Modelled IHME
1.39 (1.11 - 1.66) 1993 Modelled IHME
1.36 (1.08 - 1.64) 1992 Modelled IHME
1.33 (1.06 - 1.61) 1991 Modelled IHME
1.3 (1.04 - 1.58) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
7 (6 - 9) 2019 Modelled IHME
7 (6 - 9) 2018 Modelled IHME
7 (6 - 9) 2017 Modelled IHME
7 (5 - 9) 2016 Modelled IHME
7 (5 - 8) 2015 Modelled IHME
7 (5 - 8) 2014 Modelled IHME
7 (5 - 8) 2013 Modelled IHME
6 (5 - 8) 2012 Modelled IHME
6 (5 - 8) 2011 Modelled IHME
6 (5 - 7) 2010 Modelled IHME
6 (4 - 7) 2009 Modelled IHME
6 (4 - 7) 2008 Modelled IHME
5 (4 - 7) 2007 Modelled IHME
5 (4 - 6) 2006 Modelled IHME
5 (4 - 6) 2005 Modelled IHME
5 (4 - 6) 2004 Modelled IHME
5 (4 - 6) 2003 Modelled IHME
5 (4 - 6) 2002 Modelled IHME
5 (4 - 5) 2001 Modelled IHME
4 (4 - 5) 2000 Modelled IHME
4 (4 - 5) 1999 Modelled IHME
4 (4 - 5) 1998 Modelled IHME
4 (3 - 5) 1997 Modelled IHME
4 (3 - 5) 1996 Modelled IHME
4 (3 - 5) 1995 Modelled IHME
4 (3 - 5) 1994 Modelled IHME
4 (3 - 4) 1993 Modelled IHME
4 (3 - 4) 1992 Modelled IHME
3 (3 - 4) 1991 Modelled IHME
3 (3 - 4) 1990 Modelled IHME
14 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
38 (29 - 48) 2019 Modelled IHME
38 (29 - 48) 2018 Modelled IHME
38 (29 - 48) 2017 Modelled IHME
39 (29 - 48) 2016 Modelled IHME
39 (29 - 48) 2015 Modelled IHME
39 (30 - 48) 2014 Modelled IHME
39 (29 - 48) 2013 Modelled IHME
39 (29 - 48) 2012 Modelled IHME
39 (30 - 48) 2011 Modelled IHME
39 (30 - 48) 2010 Modelled IHME
39 (30 - 48) 2009 Modelled IHME
39 (30 - 48) 2008 Modelled IHME
39 (30 - 49) 2007 Modelled IHME
39 (30 - 49) 2006 Modelled IHME
40 (30 - 49) 2005 Modelled IHME
40 (30 - 49) 2004 Modelled IHME
40 (30 - 49) 2003 Modelled IHME
40 (30 - 50) 2002 Modelled IHME
40 (31 - 50) 2001 Modelled IHME
40 (31 - 50) 2000 Modelled IHME
40 (31 - 50) 1999 Modelled IHME
40 (31 - 50) 1998 Modelled IHME
40 (31 - 50) 1997 Modelled IHME
40 (31 - 50) 1996 Modelled IHME
40 (31 - 51) 1995 Modelled IHME
40 (31 - 50) 1994 Modelled IHME
40 (31 - 50) 1993 Modelled IHME
40 (30 - 50) 1992 Modelled IHME
40 (30 - 50) 1991 Modelled IHME
40 (30 - 50) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
190 2017 Survey/reported ECDC, 2019
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2025
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Overview

HBV elimination goal
HCV elimination goal
Year of goal
2025

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
5
2019
(4 - 6)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
7
2019
(6 - 9)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources